// App-Quantinova.ai

P1-14-10 : Phase II trial of neoadjuvant chemotherapy with carboplatin and nab-paclitaxel in patients with triple negative locally advanced and inflammatory breast cancer

Researchers

Presenter

  • Somlo G

Principal Investigators

  • Chung S

  • Frankel P

  • Waisman J

  • Yeon C

  • Yim J

  • Yuan Y

  • Tong T

  • Hurria A

  • Koehler S

  • Kruper L

  • Mortimer JE

  • Paz B

  • Robinson K

  • Taylor L

  • Vito C

Medical Centers

  • City of Hope National Medical Center, Duarte, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Carboplatin

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved